Large employers likely to continue GLP-1 coverage in 2027 (BGH survey)
Metric EN-01 · Series EN: Employer Innovation
Large employers likely to continue GLP-1 coverage in 2027 (BGH survey) was 72% in 2026, according to Business Group on Health 2026 survey (105 large-employer members).
This figure is reported as Metric EN-01 in The State of Metabolic Health in America, 2026 Baseline Edition: Annual Policy Report (James M. Knox, DOI: 10.5281/zenodo.22772957).
Definition
This metric measures large employers likely to continue glp-1 coverage in 2027 (bgh survey) among large employers already covering glp-1 treatment. The unit of measurement is percent of covering employers. The geographic scope is United States.
Current Value
| Value | Data Year | Population | Geography |
|---|---|---|---|
| 72% | 2026 | Large employers already covering GLP-1 treatment | United States |
Source
Business Group on Health 2026 survey (105 large-employer members).
Methodological Notes
This figure is drawn from Business Group on Health 2026 survey (105 large-employer members). Where a second source reports a different figure for the same condition, both values and the reason for the discrepancy are documented in the report rather than reconciled.
See Methodology and Sources for the full source selection criteria and conflict resolution approach.
Related Metrics
- EN-02Large employers unlikely to continue GLP-1 coverage in 2027 (BGH survey)
- EN-03Large employers intending to maintain GLP-1 coverage (WTW survey)
- EN-04Large employers likely or very likely to discontinue GLP-1 coverage (WTW)
- EN-05Large employers somewhat likely to discontinue GLP-1 coverage (WTW)
- EN-06Employers that dropped GLP-1 coverage in 2026 (Mercer)
Cite This Metric
Last reviewed: October 2026